Latest Comments

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Rule-breakers: rehabilitating wayward clinical researchers

Rule-breakers: rehabilitating wayward clinical researchers

Could copper unlock a new wave of metabolic treatments?

Could copper unlock a new wave of metabolic treatments?

Lupus breakthrough sparks hope in a frustrating field

Lupus breakthrough sparks hope in a frustrating field